# Added Value of Contrast Enhanced Spectral Mammography, CESM. A Pilot Study.

> **NCT03402529** · NA · COMPLETED · sponsor: **Region Skane** · enrollment: 47 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Contrast Enhanced Spectral Mammography

## Key facts

- **NCT ID:** NCT03402529
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-28
- **Primary completion:** 2018-10-19
- **Final completion:** 2018-10-19
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03402529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03402529, "Added Value of Contrast Enhanced Spectral Mammography, CESM. A Pilot Study.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03402529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*